Table 1.
Multivariate analysis of predictors of an increase in EDVI
| Multivariate |
||||
|---|---|---|---|---|
| Univariate | Model: R=0.540, p<0.001 |
|||
| r | p Value | β | p Value | |
| Age, years | 0.056 | 0.605 | – | – |
| Female, n (%) | 10.036 | 0.740 | – | – |
| Body mass index, kg/m2 | 0.168 | 0.117 | – | – |
| Family history for AMI, n (%) | 10.011 | 0.919 | – | – |
| Smoking status, n (%) | −0.151 | 0.161 | – | – |
| RRsys, mm Hg | −0.088 | 0.415 | – | – |
| RRdia, mm Hg | −0.017 | 0.875 | – | – |
| Total cholesterol, mg/dL | −0.022 | 0.847 | – | – |
| Plasma glucose at admission, mg/dL | 0.020 | 0.852 | – | – |
| Creatinine, mg/dL | 0.038 | 0.729 | – | – |
| eGFR, mL/min/1.73 m2 | −0.012 | 0.909 | – | – |
| Ischaemia time, min | −0.048 | 0.657 | – | – |
| Vessel disease, n (%) | −0.075 | 0.486 | – | – |
| cTnT max, ng/L | 0.369 | <0.001 | 0.341 | 0.033 |
| NT-proBNP max, ng/L | 0.204 | 0.061 | −0.030 | 0.787 |
| CRP max, mg/dL | 0.042 | 0.698 | – | – |
| Fetuin-A, mg/L | −0.383 | <0.001 | −0.372 | 0.001 |
| LVEF baseline, % | −0.255 | 0.017 | 0.018 | 0.880 |
| EDVI baseline, mL/m2 | −0.092 | 0.393 | – | – |
| ESVI baseline, mL/m2 | 0.102 | 0.346 | – | |
| MMED, g | 0.138 | 0.198 | – | – |
| Infarct size, g | 0.351 | 0.001 | −0.031 | 0.843 |
| Late MVO present, n (%) | 0.321 | 0.002 | 0.106 | 0.363 |
| Transmurality, n (%) | 0.282 | 0.008 | 0.030 | 0.797 |
AMI, acute myocardial infarction; CRP, C reactive protein; cTnT, cardiac troponin T; EDVI, end-diastolic volume index; eGFR, estimated glomerular filtration rate; ESVI, end-systolic volume index; LVEF, left ventricular ejection fraction; max, maximum; MMED, myocardial mass at end diastole; MVO, microvascular obstruction; NT-proBNP, N-terminal pro brain natriuretic peptide; RRdia, diastolic blood pressure; RRsys, systolic blood pressure.